loading

Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
0.03%
14.82
14.82 14.83 14.66 42.73
Operating Income/Loss
0.03%
-14.82
-14.82 -14.83 -14.66 -42.73
Income/Loss From Continuing Operations Before Tax
10.87%
-13.82
-12.46 -13.70 -13.39 -41.86
Income/Loss From Continuing Operations After Tax
10.87%
-13.82
-12.46 -13.70 -13.39 -41.86
Net Income/Loss
10.87%
-13.82
-12.46 -13.70 -13.39 -41.86
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,125%
27.01
2.2047 26.99 14.71 129.34
Diluted Average Shares
1,125%
27.01
2.2047 26.99 14.71 129.34
Basic Earnings Per Share
155.00%
-0.51
-0.20 -0.51 -0.91 -0.32
Diluted Earnings Per Share
155.00%
-0.51
-0.20 -0.51 -0.91 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.41
price up icon 1.47%
$83.38
price up icon 1.26%
$46.83
price down icon 6.86%
$410.00
price up icon 1.85%
$205.47
price down icon 0.65%
$110.64
price up icon 2.56%
Capitalizzazione:     |  Volume (24 ore):